Unihealth Consultancy (NSE:UNIHEALTH) EBIT : ₹131.7 Mil (TTM As of Mar. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Unihealth Consultancy EBIT?

Unihealth Consultancy's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2023 was ₹131.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2023 was ₹131.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Unihealth Consultancy's annualized ROC % for the quarter that ended in Mar. 2023 was 15.53%. Unihealth Consultancy's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was 29.73%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Unihealth Consultancy's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was 6.08%.

Unihealth Consultancy EBIT Historical Data

The historical data trend for Unihealth Consultancy's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unihealth Consultancy EBIT Chart

Unihealth Consultancy Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

EBIT

-0.13

63.64

101.74

131.71

Unihealth Consultancy Semi-Annual Data
	Mar20	Mar21	Mar22	Mar23
EBIT	-0.13	63.64	101.74	131.71

Competitive Comparison of Unihealth Consultancy's EBIT

For the Medical Care Facilities subindustry, Unihealth Consultancy's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unihealth Consultancy's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Unihealth Consultancy's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Unihealth Consultancy's EV-to-EBIT falls into.

Unihealth Consultancy EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was ₹131.7 Mil.

Unihealth Consultancy (NSE:UNIHEALTH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Unihealth Consultancy's annualized ROC % for the quarter that ended in Mar. 2023 is calculated as:

	ROC % (Q: Mar. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2022 )	+	Invested Capital (Q: Mar. 2023 ))	/ count )
=	113.076 * ( 1 - 17.47% )	/	( (521.749	+	679.893)	/ 2 )
=	93.3216228	/	600.821
=	15.53 %

where

	Invested Capital		(Q: Mar. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	647.865	-	102.619	-	( 23.497	-	max(0, 130.557	-	241.682	+	23.497	))
=	521.749

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	783.332	-	83.901	-	( 19.538	-	max(0, 144.874	-	332.428	+	19.538	))
=	679.893

Note: The Operating Income data used here is one times the annual (Mar. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Unihealth Consultancy's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2022		Q: Mar. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	131.706	/	( ( (287.834 + max(103.802, 0))	+	(294.567 + max(199.728, 0)) )	/	2 )
=	131.706	/	( ( 391.636	+	494.295 )	/	2 )
=	131.706	/	442.9655
=	29.73 %

where Working Capital is:

	Working Capital		(Q: Mar. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(181.926	+	17.973	+	13.677)	-	(102.619	+	0	+	7.155)
=	103.802

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(273.936	+	21.124	+	13.829)	-	(83.901	+	0	+	25.26)
=	199.728

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Unihealth Consultancy's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2023 )
	=	131.706	/	2166.453
	=	6.08 %

Unihealth Consultancy EBIT Related Terms

Thank you for viewing the detailed overview of Unihealth Consultancy's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Unihealth Consultancy (NSE:UNIHEALTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Unihealth Consultancy Ltd (NSE:UNIHEALTH) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

156 Tardeo Road, H-13 & H-14, Everest , 9th Floor, Mumbai, MH, IND, 400034

Website

https://www.unihealthonline.com

Unihealth Consultancy Ltd is a healthcare service provider based out of Mumbai, India and has an operational presence in multiple countries across the African continent. Its business segments include Medical Centres, Hospitals, Consultancy Services, Distribution of Pharmaceutical & Medical Consumable Products and Medical Value Travel. It is currently providing Project Management Consultancy Services to set up a 300+ bedded Health City in Undri, Pune (Maharashtra, India) for PHRC Lifespaces Organization along with a few other healthcare consultancy projects in Kenya and Angola. The Majority of revenue is derived from Uganda.

Unihealth Consultancy (NSE:UNIHEALTH) Headlines

No Headlines